BHARAT SEATS
RESULTS FOR Q4 FY 2017-18
MARCH 2018
BHARAT SEATS has declared good results for the fourth Quarter ended March 2018. The results are tabulated below :
BHARAT SEATS has done well in Q4 FY 17-18. Sales have gone up 13.47% YoY and 17.28% QoQ. Net Profits have gone up94% YoY and 33% QoQ. At current Market price of Rs.223, PE Ratio comes to 23. The scrip has moved up 184% during last one year from Rs.79
BHARAT SEATS | Mar '18 | Dec '17 | Sep '17 | Jun '17 | Mar '17 | YOY | QOQ |
Net Sales | 253.46 | 216.11 | 259.05 | 233.01 | 223.37 | 13.47 | 17.28 |
Total Income | 253.46 | 216.11 | 259.05 | 233.01 | 223.54 | 13.38 | 17.28 |
EXPENDITURE | |||||||
Raw Materials | 211.57 | 182.94 | 217.26 | 202.55 | 194.76 | 8.63 | 15.65 |
Traded Goods | 0.12 | 0.03 | 0.09 | 0.12 | 0.08 | 50 | 300 |
Increase/Decrease in Stocks | 0.94 | -0.83 | 0.97 | -1.45 | 0.26 | 261.54 | -213.25 |
Employees Cost | 6.83 | 5.8 | 6.16 | 6.29 | 5.3 | 28.87 | 17.76 |
Depreciation | 5.11 | 4.69 | 4.74 | 4.57 | 4.52 | 13.05 | 8.96 |
Other Expenses | 16.14 | 14.8 | 14.02 | 13.5 | 13.28 | 21.54 | 9.05 |
P/L Before Other Inc. , Int., Excpt. Items & Tax | 12.75 | 8.7 | 15.82 | 7.43 | 5.33 | 139.21 | 46.55 |
Other Income | 0.32 | 0.83 | 0.67 | 0.2 | 0.72 | -55.56 | -61.45 |
P/L Before Int., Excpt. Items & Tax | 13.07 | 9.52 | 16.49 | 7.63 | 6.05 | 116.03 | 37.29 |
Interest | 0.63 | 0.77 | 0.88 | 0.92 | 1.03 | -38.83 | -18.18 |
P B T | 12.44 | 8.75 | 15.61 | 6.71 | 5.01 | 148.3 | 42.17 |
Tax | 4.67 | 2.91 | 5.37 | 2.34 | 1 | 367 | 60.48 |
Net Profit | 7.77 | 5.84 | 10.24 | 4.37 | 4.01 | 93.77 | 33.05 |
Equity | 6.28 | 6.28 | 6.28 | 6.28 | 6.28 | 0 | 0 |
Basic EPS | 2.47 | 1.86 | 3.26 | 1.39 | 1.28 | 92.97 | 32.8 |
Diluted EPS | 2.47 | 1.86 | 3.26 | 1.39 | 1.28 | 92.97 | 32.8 |
MP | 223.05 | ||||||
PE | 22.58 | ||||||
PRICE TREND | |||||||
21.04.18 | 1 week | 2 week | 1 month | 3 month | 6 month | 9 month | 1 year |
Price | 223.4 | 201.7 | 176.3 | 240.35 | 184.3 | 124 | 78.55 |
Gain / Loss | -0.16% | 10.59% | 26.52% | -7.20% | 21.03% | 79.88% | 183.96% |
This does not constitute my recommendation for Buy / Sale / Hold. Investor need to make their own study further and decide themselves.
No comments:
Post a Comment